Synopsys, Inc. $SNPS Shares Acquired by Allianz SE

Allianz SE increased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 24.5% during the third quarter, HoldingsChannel.com reports. The fund owned 10,305 shares of the semiconductor company’s stock after purchasing an additional 2,031 shares during the period. Allianz SE’s holdings in Synopsys were worth $4,482,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. E Fund Management Hong Kong Co. Ltd. grew its stake in Synopsys by 51.3% in the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 1,645 shares of the semiconductor company’s stock valued at $715,000 after buying an additional 558 shares during the last quarter. Sumitomo Life Insurance Co. lifted its position in Synopsys by 17.7% during the 3rd quarter. Sumitomo Life Insurance Co. now owns 5,530 shares of the semiconductor company’s stock worth $2,405,000 after acquiring an additional 833 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its position in Synopsys by 340.4% during the 3rd quarter. Clal Insurance Enterprises Holdings Ltd now owns 229 shares of the semiconductor company’s stock worth $100,000 after acquiring an additional 177 shares during the last quarter. TIAA CREF Individual & Institutional Services LLC lifted its position in Synopsys by 5.8% during the 3rd quarter. TIAA CREF Individual & Institutional Services LLC now owns 1,118 shares of the semiconductor company’s stock worth $486,000 after acquiring an additional 61 shares during the last quarter. Finally, Whittier Trust Co. boosted its holdings in Synopsys by 2.9% during the third quarter. Whittier Trust Co. now owns 847 shares of the semiconductor company’s stock valued at $368,000 after acquiring an additional 24 shares during the period. 85.47% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on SNPS. Deutsche Bank reissued a “buy” rating and issued a $640.00 price objective (up from $590.00) on shares of Synopsys in a research report on Thursday, October 1st. JPMorgan Chase & Co. cut their target price on Synopsys from $650.00 to $600.00 in a research note on Thursday, August 27th. Weiss Ratings cut Synopsys from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, September 11th. KeyCorp boosted their target price on Synopsys from $600.00 to $605.00 and gave the stock an “overweight” rating in a report on Thursday, October 1st. Finally, Bank of America lifted their price target on Synopsys from $500.00 to $600.00 in a report on Thursday, October 1st. One research analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, Synopsys has an average rating of “Moderate Buy” and an average target price of $577.71.

Read Our Latest Stock Analysis on SNPS

Synopsys Stock Performance

Shares of NASDAQ:SNPS opened at $396.55 on Friday. The firm’s 50 day simple moving average is $448.46 and its 200 day simple moving average is $440.14. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24. The company has a market capitalization of $76.00 billion, a price-to-earnings ratio of 70.06, a P/E/G ratio of 1.26 and a beta of 1.18. Synopsys, Inc. has a fifty-two week low of $362.55 and a fifty-two week high of $539.48.

Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, topping analysts’ consensus estimates of $3.67 by $0.24. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The company had revenue of $2.48 billion for the quarter, compared to analysts’ expectations of $2.44 billion. During the same period last year, the firm posted $3.39 earnings per share. The business’s quarterly revenue was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, sell-side analysts forecast that Synopsys, Inc. will post 11.01 earnings per share for the current year.

Synopsys announced that its Board of Directors has initiated a share repurchase program on Monday, October 5th that authorizes the company to buy back $1 billion in outstanding shares. This buyback authorization authorizes the semiconductor company to buy up to 1.1% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s board believes its stock is undervalued.

Insiders Place Their Bets

In related news, CEO Sassine Ghazi sold 14,604 shares of the business’s stock in a transaction on Thursday, October 15th. The shares were sold at an average price of $462.84, for a total value of $6,759,315.36. Following the sale, the chief executive officer directly owned 76,865 shares of the company’s stock, valued at approximately $35,576,196.60. The trade was a 15.97% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Sudhindra Kankanwadi sold 9,170 shares of the company’s stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total value of $4,585,000.00. Following the transaction, the chief financial officer directly owned 22,717 shares of the company’s stock, valued at $11,358,500. This represents a 28.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 117,163 shares of company stock valued at $51,366,457 in the last quarter. 0.56% of the stock is owned by company insiders.

Synopsys News Summary

Investors following SNPS have been watching these news items:

  • Positive Sentiment: Barclays initiated coverage with an Overweight rating and a $640 price target, citing Synopsys’ leadership in electronic design automation, AI-related R&D tailwinds and long-term free-cash-flow potential. The bullish call was accompanied by a gain in Thursday trading. Barclays starts Synopsys at Overweight
  • Neutral Sentiment: Synopsys is described as having stronger forward growth and a lower forward valuation multiple than Cadence, but Cadence is credited with a stronger balance sheet and returns on capital. Synopsys vs. Cadence
  • Negative Sentiment: A valuation analysis argues SNPS may be about 17% overvalued despite improving guidance and business performance, raising questions about whether future cash generation justifies the share price. Synopsys may be overvalued

Synopsys Company Profile

(Free Report)

Synopsys, Inc. develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs. The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.

Featured Articles

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.